Rankings
▼
Calendar
LIVN Q1 2023 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena
LIVN
LivaNova PLC
$3B
Q1 2023 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$263M
+9.7% YoY
Gross Profit
$174M
66.1% margin
Operating Income
-$2M
-0.9% margin
Net Income
$7M
2.8% margin
EPS (Diluted)
$0.14
QoQ Revenue Growth
-4.2%
Cash Flow
Operating Cash Flow
$21M
Free Cash Flow
$13M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$2.3B
Total Liabilities
$1.1B
Stockholders' Equity
$1.2B
Cash & Equivalents
$523M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$263M
$240M
+9.7%
Gross Profit
$174M
$168M
+3.3%
Operating Income
-$2M
$10M
-124.6%
Net Income
$7M
$3M
+146.2%
Revenue Segments
Cardiopulmonary Segment
$132M
50%
Neuromodulation Segment
$121M
46%
Advanced Circulatory Support Segment
$10M
4%
Geographic Segments
UNITED STATES
$140M
53%
Locations Excluding The United States And Europe
$74M
28%
Europe
$50M
19%
← FY 2023
All Quarters
Q2 2023 →